Education
About Us
Working with TipRanks
Follow Us
Milestone Pharmaceuticals (MIST)
NASDAQ:MIST
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 1.00M | $ 5.00M | $ 15.00M | $ 0.00 |
| Gross Profit | $ 0.00 | $ 1.00M | $ 4.52M | $ 15.00M | $ -376.00K |
| Operating Income | $ -42.10M | $ -61.10M | $ -59.64M | $ -43.07M | $ -50.71M |
| EBITDA | $ -42.10M | $ -56.84M | $ -58.36M | $ -42.98M | $ -50.71M |
| Net Income | $ 0.00 | $ -59.69M | $ -57.13M | $ -42.63M | $ -49.97M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 69.69M | $ 66.00M | $ 64.58M | $ 114.14M | $ 142.31M |
| Total Assets | $ 75.50M | $ 75.23M | $ 74.48M | $ 119.85M | $ 149.97M |
| Total Debt | $ 54.80M | $ 51.77M | $ 2.49M | $ 698.00K | $ 941.00K |
| Net Debt | $ 29.48M | $ 38.02M | $ -5.14M | $ -113.44M | $ -71.37M |
| Total Liabilities | $ 62.35M | $ 58.45M | $ 8.13M | $ 7.25M | $ 6.86M |
| Stockholders' Equity | $ 13.15M | $ 16.77M | $ 66.35M | $ 112.60M | $ 143.12M |
| Cash Flow | |||||
| Free Cash Flow | $ -28.85M | $ -46.54M | $ -52.74M | $ -33.22M | $ -50.73M |
| Operating Cash Flow | $ -28.85M | $ -46.42M | $ -52.47M | $ -33.22M | $ -50.73M |
| Investing Cash Flow | $ 8.28M | $ 4.76M | $ -57.12M | $ 70.00M | $ -70.00M |
| Financing Cash Flow | $ 32.12M | $ 47.79M | $ 3.09M | $ 5.05M | $ 73.22M |